Novartis’ Kisqali plus endocrine therapy shows significant PFS benefits in advanced breast cancer trials

pharmanewsdaily- December 9, 2018 0

Swiss pharmaceutical giant Novartis has announced that its breast cancer drug, Kisqali (ribociclib), when used in combination with endocrine therapy, has demonstrated substantial efficacy in ... Read More

Oncternal Therapeutics launches Phase 1b trial of Cirmtuzumab in combination with Paclitaxel in breast cancer

pharmanewsdaily- September 13, 2018 0

Oncternal Therapeutics, a leading U.S. oncology company, has announced the dosing of the first patient in a phase 1b trial of its investigational drug cirmtuzumab, ... Read More

EVA smart bra developed to detect early signs of breast cancer

pharmanewsdaily- April 30, 2018 0

An all new smart bra dubbed as EVA Smart Bra has been developed by a Mexican teenager that can potentially be a life saver for ... Read More

Five Reasons Why You Should Take Off Your Bra Before Sleeping

pharmanewsdaily- April 29, 2018 0

Did you ever wonder whether sleeping with your bra on can create problems for you? Then, you are right, experts are advising to take off ... Read More

Cannabis oil benefits breast cancer | Cannabis oil for cancer treatment in India

pharmanewsdaily- April 21, 2018 0

As per the latest research reports, it was found that cannabis oil compounds are capable of killing malignant cells of cancer. Cannabis is used as ... Read More

Lilly’s breast cancer drug abemaciclib shows promising results in phase 3 trial

pharmanewsdaily- March 22, 2017 0

Indianapolis-based pharmaceutical giant Lilly has announced positive outcomes from its phase 3 clinical trial, MONARCH 2, involving its innovative breast cancer treatment, abemaciclib, in combination ... Read More

Roche’s Perjeta shows significant promise in phase 3 breast cancer trial

pharmanewsdaily- March 2, 2017 0

Roche has announced promising results from the APHINITY trial, a crucial Phase 3 study evaluating Perjeta (pertuzumab) in combination with Herceptin (trastuzumab) and chemotherapy. This ... Read More

University of Antwerp launches pioneering clinical trial to combat cognitive deficits in breast cancer patients

pharmanewsdaily- October 22, 2016 0

The University of Antwerp in Belgium has initiated an innovative clinical trial aimed at mitigating the cognitive deficits associated with breast cancer treatment, marking a ... Read More

1...34548 / 48 Posts